直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Lauren J. Robinson
Partner
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4426
lauren.robinson@finnegan.com lauren.robinson@finnegan.com

Lauren J. Robinson

Partner

  • +1 202 408 4426 +1 202 408 4426
  • lauren.robinson@finnegan.com lauren.robinson@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Lauren Robinson is experienced in intellectual property litigation and transactional matters. She focuses on complex patent litigation before U.S. district courts in the chemical and pharmaceutical fields.

Lauren's litigation experience covers numerous aspects of trial preparation, including conducting discovery and handling day-to-day litigation activities. In particular, she has extensive litigation experience involving the Hatch-Waxman Act, which governs the approval of pharmaceutical products. She also serves as an adjunct professor at the George Mason University Antonin Scalia Law School, teaching in the area of patent litigation.

In addition to litigation, Lauren counsels domestic and international clients regarding U.S. intellectual property law by providing infringement and validity opinions, and by advising them in licensing, antitrust, due diligence, and IP portfolio matters. She also counsels clients regarding patent applications pending before the U.S. Patent and Trademark Office (USPTO).

Et Cetera

  • Served as research editor for the Florida Law Review, Spring 2013.
  • Examined patents during the USPTO Patent Experience Externship Program, Summer 2012.

Experience

Bausch Health Ireland Limited et al. v. Aurobindo Pharma Limited et al.

Represented Bausch Health et al. in Abbreviated New Drug Application (ANDA) litigation involving Trulance® (plecanatide) tablets for the treatment of irritable bowel syndrome and chronic idiopathic constipation, resulting in favorable settlement post-trial. 

2:23-cv-00170, D.N.J., Judge Chesler
1:21-cv-00611, D. Del., Judge Stark
1:22-cv-00085, N.D.W. Va., Judge Kleeh
2:21-cv-00573, W.D. Pa., Judges Cercone, Hardy
1:22-cv-00020, N.D.W. Va., Judge Kleeh
2:21-cv-10057, D.N.J., Judge Chesler
2:21-cv-10403, D.N.J., Judge Chesler
2:23-cv-03333, D.N.J., Judge Chesler
1:24-cv-00036, N.D.W. Va., Judge Kleeh
2:24-cv-07182, D.N.J., Judge Chesler
2:24-cv-11179, D.N.J., Judge Chesler
1:25-cv-00003, N.D.W. Va., Judge Kleeh
IPR2023-00016, PTAB, Judges Hardman, Hulse, Valek
IPR2022-00722, - 01102, -01103, -01104, -01105, PTAB, Judges Hardman, Hulse, Snedden, Valek

Bial - Portela & CA S.A. v. Alkem Laboratories Ltd et al.

Represented Bial in district court Hatch-Waxman litigation involving the anti-epileptic drug Aptiom®.

1:18-cv-00304, D. Del., Judges Connolly, Burke

Insights

Webinar

Patent Term at Risk? Navigating OTDP’s Impact on PTA, PTE, and Reissue in Light of Recent Federal Circuit Decisions Patent Term at Risk? Navigating OTDP’s Impact on PTA, PTE, and Reissue in Light of Recent Federal Circuit Decisions

November 20, 2025

Webinar

Webinar

Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions

June 11, 2025

Webinar

Articles

Implications of California's AB 824 Patent Settlement Regulation

Implications of California's AB 824 Patent Settlement Regulation Implications of California's AB 824 Patent Settlement Regulation

May 21, 2025

Life Science Leader

Webinar

IP Challenges in Protecting Life Sciences Innovations IP Challenges in Protecting Life Sciences Innovations

September 18, 2024

Webinar

Articles

Breeders’ Rights No Longer a Pipe Dream for New Marijuana Varieties?

Breeders’ Rights No Longer a Pipe Dream for New Marijuana Varieties? Breeders’ Rights No Longer a Pipe Dream for New Marijuana Varieties?

August 13, 2024

Cannabis Business Executive

Prosecution First Blog

Filing of Plant Applications in USPTO’s Patent Center Appears to Have Taken Root Filing of Plant Applications in USPTO’s Patent Center Appears to Have Taken Root

June 7, 2024

More

News

Award/Ranking

Best Lawyers Recognizes 44 Finnegan Attorneys in its 2026 Edition of The Best Lawyers and Ones to Watch Best Lawyers Recognizes 44 Finnegan Attorneys in its 2026 Edition of The Best Lawyers and Ones to Watch

August 21, 2025

Best Lawyers

Award/Ranking

31 Finnegan Attorneys Recognized by Best Lawyers 31 Finnegan Attorneys Recognized by Best Lawyers

August 15, 2024

Best Lawyers

Press Release

32 Finnegan Attorneys Recognized by Best Lawyers

32 Finnegan Attorneys Recognized by Best Lawyers

August 17, 2023

Best Lawyers

Press Release

Finnegan Elects Eight New Partners Finnegan Elects Eight New Partners

January 3, 2023

Press Release

29 Finnegan Attorneys Ranked by Best Lawyers

29 Finnegan Attorneys Ranked by Best Lawyers

August 18, 2022

U.S. News—Best Lawyers

Press Release

Twenty Finnegan Attorneys Recognized by Best Lawyers Twenty Finnegan Attorneys Recognized by Best Lawyers

August 20, 2021

U.S. News—Best Lawyers
More

Professional Activities

  • Order of the Coif
  • American Institute of Chemical Engineers (AIChE)
Admissions and Education

Admissions

  • U.S. Patent and Trademark Office
  • District of Columbia
  • Virginia

 

Education

University of Florida College of Law
J.D., magna cum laude, 2014
University of Florida
B.S., Chemical Engineering, cum laude, 2011

Lauren's Practices

Appeals, Issues, and Legal Strategy
Federal Circuit and Supreme Court Appeals
Global IP Enforcement, Litigation, and Trials
Antitrust and Misuse
Branded Hatch-Waxman (ANDA) Litigation and Trials
Federal Circuit and Supreme Court Appeals
Patent Litigation and Trials
Prosecution and Portfolio Management
Due Diligence
Licensing, Pooling, and Other Transactions
Opinions and Counseling

Lauren's Industries

Chemicals, Industrials, and Materials
Chemical
Life Sciences
Biotechnology
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP